Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea.
Human papillomavirus
Human papillomavirus vaccine
Korea
Recurrent respiratory papillomatosis
Journal
Epidemiology and health
ISSN: 2092-7193
Titre abrégé: Epidemiol Health
Pays: Korea (South)
ID NLM: 101519472
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
09
2020
accepted:
10
03
2021
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
19
5
2021
Statut:
ppublish
Résumé
Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11 and is potentially preventable through vaccination. This study estimated the incidence of juvenile-onset RRP before the implementation of the national HPV vaccination program in Korea. We conducted a cohort study using claims data provided by a mandatory insurance program to estimate the incidence of RRP and associated healthcare use. Patients with juvenile RRP were defined as those aged ≤12 years with ≥2 admissions or ≥2 outpatient visits during which they received the International Classification of Diseases, 10th revision code for benign neoplasms of the larynx (D14.1). During 2002-2014, 123 children (74 boys and 49 girls) were diagnosed with RRP. The patients had a mean of 6.5 person-years of follow-up. The incidence was estimated at 0.30/100,000 person-years. The median age at diagnosis was 4.0 years (mean, 4.3). Thirty-six (29.3%) patients underwent surgery, including 23 patients (18.7%) who underwent 2 or more surgical procedures. Severe disease, measured by more frequent surgical procedures and shorter time intervals between consecutive operations, was associated with a younger age at diagnosis. The estimated incidence of juvenile-onset RRP in Korea was similar to that reported in other countries. The RRP burden should continue to be monitored using National Health Insurance Service claims data.
Identifiants
pubmed: 33906285
pii: epih.e2021019
doi: 10.4178/epih.e2021019
pmc: PMC8189843
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2021019Subventions
Organisme : National Cancer Center
ID : NCC-2010303
Pays : Republic of Korea
Organisme : National Cancer Center
ID : NCC-1710141
Pays : Republic of Korea
Références
Sex Transm Dis. 2014 May;41(5):300-5
pubmed: 24722383
PLoS One. 2014 Jun 11;9(6):e99114
pubmed: 24918765
J Formos Med Assoc. 2006 Jun;105(6):508-11
pubmed: 16801040
Int J Pediatr Otorhinolaryngol. 2014 Dec;78(12):2113-5
pubmed: 25300480
Int J Pediatr Otorhinolaryngol. 2014 Feb;78(2):186-97
pubmed: 24367938
Respir Med. 2017 May;126:116-121
pubmed: 28427542
Clin Otolaryngol. 2018 Apr;43(2):533-537
pubmed: 29054106
Obstet Gynecol. 2003 Apr;101(4):645-52
pubmed: 12681865
Ther Clin Risk Manag. 2015 May 05;11:731-8
pubmed: 25999724
J Bras Pneumol. 2008 Dec;34(12):1084-9
pubmed: 19180346
Int J Epidemiol. 2017 Jun 1;46(3):799-800
pubmed: 27794523
Otolaryngol Clin North Am. 2012 Jun;45(3):671-94, viii-ix
pubmed: 22588043
Diagn Interv Radiol. 2009 Jun;15(2):93-5
pubmed: 19517378
Laryngoscope. 2012 Jul;122(7):1595-9
pubmed: 22565595
Clin Infect Dis. 2000 Jul;31(1):107-9
pubmed: 10913405
Case Rep Oncol. 2011 Mar 23;4(1):162-71
pubmed: 21526134
PLoS One. 2019 Jun 13;14(6):e0216697
pubmed: 31194767
Acta Otorhinolaryngol Ital. 2014 Dec;34(6):375-81
pubmed: 25762828
Arch Otolaryngol Head Neck Surg. 2003 Sep;129(9):976-82
pubmed: 12975271
Clin Otolaryngol. 2017 Feb;42(1):86-91
pubmed: 27208548
Laryngoscope. 2010 Jun;120(6):1233-45
pubmed: 20513045
J Infect Dis. 2018 Jan 4;217(2):208-212
pubmed: 29136168
Vaccine. 2012 Nov 20;30 Suppl 5:F34-54
pubmed: 23199965
Laryngoscope. 2016 Dec;126(12):2827-2832
pubmed: 27074766